NCT07833748

Brief Summary

Parkinson's disease is a progressive neurodegenerative condition characterized by both motor symptoms (such as bradykinesia, rigidity, tremor, and postural instability) and non-motor symptoms, including cognitive impairments (affecting working memory, executive functions, and attention). Combined interventions that target both domains simultaneously or consecutively have shown potential to produce superior benefits compared to isolated motor or cognitive training. The purpose of this study is to evaluate the feasibility, adherence, and preliminary clinical results of efficacy of an integrated and combined motor-cognitive rehabilitation training in patients diagnosed with Parkinson's disease. This feasibility study will enroll 12 participants with Parkinson's disease. All participants will undergo a comprehensive 10-session integrated rehabilitation program combining digital cognitive individual stimulation and group functional motor training. The primary focus is to assess acceptability, safety, and adherence to this combined approach, while secondary outcomes will observe changes in relevant cognitive and motor clinical variables.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2026

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

September 10, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

September 22, 2026

Completed
Last Updated

September 22, 2026

Status Verified

September 1, 2026

Enrollment Period

3 months

First QC Date

September 10, 2026

Last Update Submit

September 16, 2026

Conditions

Keywords

Parkinson DiseaseMotor-Cognitive TrainingCognitive RehabilitationMotor Rehabilitation

Outcome Measures

Primary Outcomes (11)

  • Feasibility Outcomes: Eligibility Rate

    Calculated as the ratio of eligible patients to the total number of screened patients.

    Baseline

  • Feasibility Outcomes: Recruitment Rate

    Calculated as the ratio of recruited patients to total eligible patients.

    Baseline

  • Feasibility Outcomes: Monthly Recruitment Rate

    Defined as the average number of participants enrolled per month.

    Baseline

  • Feasibility Outcomes: Drop-out Rate

    The percentage of participants who withdraw from the study.

    score changes after intervention (4 weeks, T1)

  • Feasibility Outcomes: Adherence Rate

    The percentage of scheduled training sessions attended

    score changes after intervention (4 weeks, T1)

  • Feasibility Outcomes: Longitudinal Retention Rate

    The percentage of enrolled participants who complete all follow-up assessments

    Post-intervention follow-up assessment (3 months after intervention completion)

  • Feasibility Outcomes: Self-Reported Acceptability

    Participants will complete a questionnaire at the end of the intervention to evaluate their subjective experience, perceived benefits, and difficulties of the treatment. Items are rated on a 5-point Likert scale ranging from 1 ("low") to 5 ("extremely high"), with higher scores indicating a more positive evaluation or greater perceived benefit/difficulty.

    score changes after intervention (4 weeks, T1)

  • Feasibility Outcomes: Adverse Events

    The incidence and severity of any adverse events (e.g., falls or excessive fatigue) recorded during the study.

    score changes after intervention (4 weeks, T1)

  • Feasibility Outcomes: Motor Exercise Intensity

    The Borg Rating of Perceived Exertion (RPE) will be used to monitor and quantify physical and cognitive effort. Total score ranges from 6 to 20. Higher scores indicate greater perceived exertion

    Monitored during every training session (Up to 4 weeks, from Sessions 1 through 10)

  • Feasibility Outcomes: Motor Exercise Exertion

    The Borg Intensity Scale-Exerciser (BIS-E) will be used to quantify exertion. Total score ranges from 0 to 30, higher scores indicate greater perceived balance effort, difficulty, and postural instability during circuit stations.

    Monitored during every training session (Up to 4 weeks, from Sessions 1 through 10)

  • Feasibility Outcomes: Digital Cognitive Progression Index (NeuronUP Activity Score)

    Digital Cognitive Progression Index (NeuronUP Activity Score) will be used to quantifies session-by-session cognitive performance and adaptive difficulty progression across the 10 training sessions. The score is calculated using NeuronUP's standardized algorithm based on accuracy, total completed phases, and maximum difficulty reached, yielding a score from 0 to 100. Higher scores reflect greater task proficiency and successful progression to higher difficulty levels. This metric serves as an exploratory/feasibility measure of intra-intervention cognitive learning.

    Monitored during every training session (Up to 4 weeks, from Sessions 1 through 10)

Secondary Outcomes (13)

  • Motor Outcomes: Change in dynamic balance, mobility, and gait

    Baseline (T0), post-treatment (4 weeks, T1), and follow-up (T2, 3 months post-treatment)

  • Motor Outcomes: Change in Gait speed

    Baseline (T0), post-treatment (4 weeks, T1), and follow-up (T2, 3 months post-treatment)

  • Motor Outcomes: Change in Distance Walked

    Baseline (T0), post-treatment (4 weeks, T1), and follow-up (T2, 3 months post-treatment)

  • Motor Outcomes: Change in Dynamic Balance

    Baseline (T0), post-treatment (4 weeks, T1), and follow-up (T2, 3 months post-treatment)

  • Motor Outcomes: Change in Finger motor speed

    Baseline (T0), post-treatment (4 weeks, T1), and follow-up (T2, 3 months post-treatment)

  • +8 more secondary outcomes

Study Arms (1)

Combined Motor-Cognitive Training Group

EXPERIMENTAL

Participants will receive a 10-session integrated rehabilitation program combining individual digital cognitive stimulation and group functional motor training

Behavioral: Combined group motor training and individual digital cognitive stimulation

Interventions

Participants complete a 10-session motor-cognitive training program (3 times per week). Interventions occur on the same day in groups of 3, supervised by a neuropsychologist and physiotherapist. * Cognitive Session (30 min): Training delivered individually and tailored to baseline, individual-specific deficits using the NeuronUP application. Each session includes 5 gamified exercise types (4 minutes each) with adaptive difficulty and optional 2-minute breaks. * Motor Session (1 h): Group circuit of 6 stations (7 minutes for station, 2-min breaks): Stations 1-2: Cardiovascular (stepping, sit-to-stand); 3: Dynamic balance with external constraints (stepping over obstacles); 4: Dynamic balance with internal constraints (walking around obstacles); 5: Static balance exercises; 6: Functional movement transfers (Floor-to-standing)

Combined Motor-Cognitive Training Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of Parkinson's disease
  • Presence of motor symptoms attributable to Parkinson's disease
  • Availability to participate in both treatments (cognitive and motor)
  • Severity of symptoms compatible with participation in group physical therapy
  • Absence of other medical conditions that could interfere with treatment delivery
  • Montreal Cognitive Assessment (MoCA) score \>= 18
  • Consent to participate in group-based motor training
  • Absence of falls in the 3 months prior to baseline evaluation

You may not qualify if:

  • Concomitant major neurological or psychiatric disorders
  • Severe cardio-pulmonary, renal, or hepatic diseases
  • Changes in baseline pharmacological therapy within 3 months prior to enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ferrara University Hospital

Ferrara, FE, 44124, Italy

RECRUITING

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Central Study Contacts

Sofia Straudi, MD, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 10, 2026

First Posted

September 22, 2026

Study Start

June 1, 2026

Primary Completion

August 31, 2026

Study Completion

September 1, 2026

Last Updated

September 22, 2026

Record last verified: 2026-09

Locations